{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:44:53Z","timestamp":1793659493803,"version":"4.5.1"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0092153","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T20:45:18Z","timestamp":1395780318000},"page":"e92153","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":389,"title":["Low 2012\u201313 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses"],"prefix":"10.1371","volume":"9","author":[{"given":"Danuta M.","family":"Skowronski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed Z.","family":"Janjua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Sabaiduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Eshaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Luise","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Gubbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Petric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Charest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bastien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trijntje L.","family":"Kwindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salaheddin M.","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Van Caeseele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"issue":"(5)","key":"ref1","first-page":"7","article-title":"Interim estimates of influenza vaccine effectiveness in 2012\/13 from Canada's sentinel surveillance network, January 2013","volume":"18","author":"DM Skowronski","year":"2013","journal-title":"Euro Surveill"},{"key":"ref2","unstructured":"Public Health Agency of Canada. FluWatch. Available: http:\/\/www.phac-aspc.gc.ca\/fluwatch\/12-13\/index-eng.php<\/ext-link>. Accessed 2013 Dec 7."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v39i00a04","article-title":"Statement on seasonal influenza vaccine for 2013\u20132014","volume":"39","year":"2013","journal-title":"Can Commun Dis Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMp1300375","article-title":"Epidemic influenza\u2014responding to the expected but unpredictable","volume":"368","author":"J Bresee","year":"2013","journal-title":"N Engl J Med"},{"key":"ref5","unstructured":"Centers for Disease Control and Prevention (CDC). FluView. Atlanta, GA: CDC. Available: http:\/\/www.cdc.gov\/flu\/weekly\/pastreports.htm<\/ext-link>. Accessed 2013 Dec 7."},{"key":"ref6","unstructured":"BC Centre for Disease Control (2013) British Columbia Annual Summary of Reportable Diseases 2012. Available: http:\/\/www.bccdc.ca\/util\/about\/annreport\/default.htm<\/ext-link>. Accessed 2013 Dec 7."},{"key":"ref7","unstructured":"BC Centre for Disease Control (2013) Influenza immunization coverage in BC health care facilities. Available: http:\/\/www.bccdc.ca\/imm-vac\/BCImmunizationCov\/flucoverage\/default.htm<\/ext-link>. Accessed 2013 Dec 7."},{"key":"ref8","first-page":"119","article-title":"Interim adjusted estimates of seasonal influenza vaccine effectiveness \u2013 United States, February 2013","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2807\/ese.18.07.20400-en","article-title":"Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012\/13","volume":"18","author":"M Valenciano","year":"2013","journal-title":"Euro Surveill"},{"key":"ref10","unstructured":"World Health Organization. WHO recommendations on the composition of influenza virus vaccines. Available: http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/en\/index.html<\/ext-link>. Accessed 2013 Dec 7."},{"key":"ref11","unstructured":"National Institute for Biological Standards and Control (2012) Influenza Reagent \u2013 Influenza virus infectious IVR-165. Available: http:\/\/www.nibsc.org\/documents\/ifu\/11-220.pdf<\/ext-link>. Accessed 2013 Dec 7."},{"key":"ref12","first-page":"181","article-title":"Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004\u20132005","volume":"31","author":"DM Skowronski","year":"2005","journal-title":"Can Commun Dis Rep"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/j.vaccine.2006.10.002","article-title":"Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005\u20132006 season of dual A and B vaccine mismatch in Canada","volume":"25","author":"DM Skowronski","year":"2007","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/595862","article-title":"Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006\u20132007","volume":"199","author":"DM Skowronski","year":"2009","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/infdis\/jis283","article-title":"Estimates of influenza vaccine effectiveness for 2007\u201308 from Canada's sentinel surveillance system: Cross-protection against major and minor variants","volume":"205","author":"NZ Janjua","year":"2012","journal-title":"J Infect Dis"},{"issue":"(4)","key":"ref16","doi-asserted-by":"crossref","first-page":"e1000258","DOI":"10.1371\/journal.pmed.1000258","article-title":"Association between the 2008\u201309 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada","volume":"7","author":"DM Skowronski","year":"2010","journal-title":"PLoS Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"c7297","DOI":"10.1136\/bmj.c7297","article-title":"Effectiveness of AS03-adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009","volume":"342","author":"DM Skowronski","year":"2011","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/cis431","article-title":"A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010\u201311 season","volume":"55","author":"DM Skowronski","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref19","article-title":"Influenza A\/subtype and B\/lineage effectiveness estimates for the 2011\u201312 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine","author":"DM Skowronski","year":"2014","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v38i00a02","article-title":"Statement on seasonal influenza vaccine for 2012\u20132013","volume":"38","year":"2012","journal-title":"Can Commun Dis Rep"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/eri.11.51","article-title":"Serologic assays for influenza surveillance, diagnosis and vaccine evaluation","volume":"9","author":"JM Katz","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1126\/science.286.5446.1921","article-title":"Predicting the evolution of human influenza A","volume":"286","author":"RM Bush","year":"1999","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1098\/rstb.2001.1001","article-title":"The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin","volume":"356","author":"GG Brownlee","year":"2001","journal-title":"Phil Trans R Soc Lond"},{"key":"ref24","unstructured":"World Health Organization (2011) WHO information for molecular diagnosis of influenza virus in humans \u2013 update. Available: http:\/\/www.who.int\/influenza\/resources\/documents\/molecular_diagnosis_influenza_virus_humans_update_201108.pdf<\/ext-link>. Accessed 2013 Dec 7."},{"key":"ref25","unstructured":"Statistics Canada. Table 105-0502 \u2013 Health indicator profile, two year period estimates, by age group and sex, Canada, provinces, territories, health regions (2012 boundaries) and peer groups, occasional, CANSIM [database]. Available: http:\/\/www.statcan.gc.ca\/tables-tableaux\/sum-som\/l01\/cst01\/health102b-eng.htm<\/ext-link>. Accessed 2013 Dec 7."},{"issue":"(3)","key":"ref26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.12927\/hcq.2008.19859","article-title":"Population patterns of chronic health conditions, comorbidity and healthcare use in Canada: implications for policy and practice","volume":"11","author":"AM Broemeling","year":"2008","journal-title":"Healthc Q"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1021\/bi00155a013","article-title":"Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography","volume":"31","author":"NK Sauter","year":"1992","journal-title":"Biochemistry"},{"key":"ref28","unstructured":"The PyMOL Molecular Graphics System, Version 1.6 Schr\u00f6dinger, LLC."},{"key":"ref29","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2014) Influenza virus characterisation. Summary Europe, September 2013. Surveillance report. Stockholm: ECDC. Available: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/influenza-virus-characterisation-sep-2013.pdf<\/ext-link>. Accessed 2014 Feb 4."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1126\/science.1186430","article-title":"Structural basis of pre-existing immunity to the 2009 H1N1 pandemic influenza virus","volume":"328","author":"R Xu","year":"2010","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMp048290","article-title":"Weathering the influenza vaccine crisis","volume":"351","author":"J Treanor","year":"2004","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.1980030206","article-title":"Clinical influenza virus and the embryonated hen's egg","volume":"3","author":"JS Robertson","year":"1993","journal-title":"Rev Med Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1099\/0022-1317-74-10-2047","article-title":"The role of amniotic passage in the egg-adaptation of human influenza virus is revealed by haemagglutinin sequence analyses","volume":"74","author":"JS Robertson","year":"1993","journal-title":"J Gen Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/160.2.191","article-title":"Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs","volume":"160","author":"JM Katz","year":"1989","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1099\/0022-1317-74-11-2513","article-title":"Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses","volume":"74","author":"EP Rocha","year":"1993","journal-title":"J Gen Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1073\/pnas.0903427106","article-title":"Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines","volume":"106","author":"W Ndifon","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e41895","DOI":"10.1371\/journal.pone.0041895","article-title":"Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses","volume":"7","author":"L Popova","year":"2012","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.virol.2005.03.010","article-title":"Two residues in the hemagglutinin of A\/Fujian\/411\/02-like influenza viruses are responsible for antigenic drift from A\/Panama\/2007\/99","volume":"336","author":"H Jin","year":"2005","journal-title":"Virology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2010.03.078","article-title":"The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response","volume":"28","author":"Z Chen","year":"2010","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1126\/science.1244730","article-title":"Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution","volume":"342","author":"BF Koel","year":"2013","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and metaanalysis","volume":"12","author":"MT Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","article-title":"Variable efficacy of repeated annual influenza vaccination","volume":"96","author":"DJ Smith","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","unstructured":"World Health Organization. Influenza updates. Available: http:\/\/www.who.int\/influenza\/surveillance_monitoring\/updates\/en\/<\/ext-link>. Accessed 2014 Jan 29."},{"issue":"(6)","key":"ref44","doi-asserted-by":"crossref","first-page":"e38929","DOI":"10.1371\/journal.pone.0038929","article-title":"Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B\/Yamagata dominance","volume":"7","author":"DM Skowronski","year":"2012","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/INF.0b013e31822db4dc","article-title":"Influenza B\/Victoria antigen induces strong recall of B\/Yamagata but lower B\/Victoria response in children primed with two doses of B\/Yamagata","volume":"30","author":"DM Skowronski","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vaccine.2011.10.062","article-title":"Antibody persistence and response to 2010\u201311 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children","volume":"30","author":"V Gilca","year":"2011","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1741-7015-11-153","article-title":"Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis","volume":"11","author":"AC Tricco","year":"2013","journal-title":"BMC Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1016\/j.vaccine.2009.08.050","article-title":"Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort","volume":"27","author":"SA Irving","year":"2009","journal-title":"Vaccine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ije\/dym021","article-title":"Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness","volume":"36","author":"EW Orenstein","year":"2007","journal-title":"Int J Epidemiol"},{"key":"ref50","unstructured":"Gilmour H, Hofmann N (2010) H1N1 vaccination. Health Reports 21(4). Statistics Canada, Catalogue no. 82-003-XPE. Available: http:\/\/www.statcan.gc.ca\/pub\/82-003-x\/2010004\/article\/11348-eng.pdf<\/ext-link>. Accessed 2013 Dec 7."},{"issue":"(37)","key":"ref51","doi-asserted-by":"crossref","first-page":"pii:20585","DOI":"10.2807\/1560-7917.ES2013.18.37.20585","article-title":"The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomized double-blind placebo-controlled trials","volume":"18","author":"G De Serres","year":"2013","journal-title":"Euro Surveill"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0092153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:21:44Z","timestamp":1648686104000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0092153"}},"subtitle":[],"editor":[{"given":"Gary P.","family":"Kobinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0092153","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,25]]}}}